NCT00830622
- Conditions
- AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
- Locations
-
- University of Nairobi Clinics Nairobi, Kenya
Clinical trial condition
Sexually Transmitted Diseases, Viral
Explore clinical trials studying Sexually Transmitted Diseases, Viral. Study availability and eligibility vary by location and protocol.
6,131 public trials
362 recruiting studies
Sexually Transmitted Diseases, Viral trial results
NCT00389194
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +18 more
- Locations
-
- Academic Medical Centre Amsterdam, Netherlands
NCT00389402
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
- Locations
-
- Academic Medical Centre, University of Amsterdam Amsterdam, Netherlands
NCT00244712
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
- Locations
-
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Beverly Hills, California, United States
NCT00227357
- Conditions
- AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +24 more
- Locations
-
- The CORE Center Chicago, Illinois, United States
NCT00476723
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +20 more
- Locations
-
- HIV-NAT Bangkok, Thailand
NCT00405925
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
- Locations
-
- Rijnstate Hospital Arnhem, Gelderland, Netherlands
NCT00230061
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +18 more
- Locations
-
- Erasmus Medical Center Rotterdam, Netherlands
NCT01135251
- Conditions
- AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +23 more
- Locations
-
- Aurora Hospital Triple Research Port Elizabeth, South Africa
Completed
Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-infected Subjects
NCT00623259
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- Washington University St Louis, Missouri, United States